Examples of subpopulations include but are not limited to metabolic dysfunction-associated steatotic liver disease (MASLD), metabolic dysfunction-associated steatohepatitis (MASH), hepatitis B virus (HBV), hepatocellular carcinoma (HCC), primary biliary cholangitis (PBC), primary sclerosing cholangitis (PSC), cirrhosis, ALPHA 1, alcoholic liver disease (ALD), and Wilson's disease
Use with caution in patients with renal or hepatic impairment
Download a Free Sample To learn more about this report, Impact of Supply Chain Disruption on GLP-1 Receptor Agonist Market The GLP-1 receptor agonist market is highly exposed to supply chain disruptions because it relies on globally sourced active pharmaceutical ingredients, peptide manufacturing capacity, injectable delivery devices, sterile packaging materials, cold-chain logistics, and specialized production facilities that must comply with stringent regulatory standards
September 19, 2025 10:48 View More Beyond the Hype The Truth About GLP-1s, Weight Loss & Healing with Melissa Afflerbach In this special in-person episode of the Modern Thyroid and Wellness podcast, host McCall McPherson is joined by Melissa Afflerbach, Program Director at Modern Weight Loss, for a candid and empowering discussion about GLP-1 medications like semaglutide and their evolving role in weight loss and metabolic health
GLP-1 (glucagon-like peptide-1) is a powerful hormone that helps regulate blood sugar, reduce appetite, and support weight management
Mobility is crucial for many users who switch between devices throughout the day, and a well-optimized boombet app demonstrates how responsive layouts, efficient caching, and intuitive menus can make short sessions just as enjoyable as longer evenings
